SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems VS-7375 clinical update is driving attention, with reported anti-tumor activity in pancreatic and other KRAS G12D cancers prompting favorable comparisons with competing drugs. Traders are weighing that early promise against questions about durability and the small cohorts, while the share offering has raised dilution concerns amid a weak share-price reaction.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidias global settlement with United Therapeutics ends the pending litigation and preserves YUTREPIA sales for PAH, driving relief buying and speculation about a short squeeze. Traders remain divided, with skeptics emphasizing the loss of the PH-ILD indication and the settlements financial burden.

Bank of America Corp. is a bank and financial holding company, which engages in the provision of banking and nonbank financial services. It operates through the following segments: Consumer Banking, Global Wealth and Investment Management (GWIM), Global Banking, Global Markets, and All Other. The Consumer Banking segment offers credit, banking, and investment products and services to consumers and small businesses. The GWIM segment focuses on solutions to meet clients’ needs through a full set of investment management, brokerage, banking, and retirement products. The Global Banking segment deals with lending-related products and services, integrated working capital management and treasury solutions to clients, and underwriting and advisory services. The Global Markets segment includes sales and trading services, as well as research, to institutional clients across fixed-income, credit, currency, commodity, and equity businesses. The All Other segment consists of asset and liability management activities, equity investments, non-core mortgage loans and servicing activities, the net impact of periodic revisions to the mortgage servicing rights valuation model for both core and non-core MSRs, other liquidating businesses, residual expense allocations and other. The company was founded by Amadeo Peter Giannini in 1904 and is headquartered in Charlotte, NC.

Bank Of America Corp.

Bank of America Corp

Bank of America is drawing attention after regulators imposed a historic penalty over anti-money-laundering and sanctions-compliance failures, with the charge weighing on discussion ahead of quarterly earnings. Traders are split between viewing the violations as a serious governance and reputational risk and treating the financial hit as manageable, with some looking to buy the dip.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Skydance Corp. - Ordinary Shares - Class B

Skydances warrant distribution and ex-warrant trading are driving discussion, with traders debating whether the share-price adjustment reflects value moving into the warrants or added selling and dilution concerns. Bearish views also point to the heavy debt taken on for the Warner Bros. Discovery acquisition, while some holders argue the warrants offset part of the decline.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Discussion centers on CAN-2409 prostate-cancer biomarker data showing immune activation and the companys planned Q4 BLA submission. Bullish traders view the data as support for the treatment and regulatory filing, while skeptics point to the share-price decline, CEO share sales, and concerns about filing timing and potential dilution.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

A clarification that OpenAIs revenue run rate was below widely circulated estimates has weighed on AI infrastructure stocks, prompting concerns about demand and returns for CoreWeaves debt-funded expansion. Traders are divided between seeing the selloff as an overreaction to an accounting comparison and worrying that heavy borrowing, costly financing, and future capital needs could pressure the business.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASMLs quarterly results and outlook are driving discussion: the company raised its full-year sales forecast and said planned equipment supply would not fully meet demand in 2027 and 2028, while quarterly revenue narrowly missed expectations. Traders are divided between viewing the AI-driven demand signals as strong and treating the share decline and lack of 2027 guidance as a sell-the-news warning.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas launch of Regna AI with Palantir is the dominant catalyst, drawing attention to the companys push into mission-specific AI for defense and edge deployments beyond its drone hardware business. Bulls see potential in the expanded partnership and speculate about short covering, while skeptics argue the announcement lacks demonstrated financial impact and point to dilution, losses, and weak price action.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA review documents highlighting a comparatively weak response rate for Revolution Medicines daraxonrasib in KRAS G12D pancreatic cancer have fueled concern about the drugs efficacy across mutation subgroups and intensified comparisons with rival KRAS G12D programs. Some traders see the reaction as overdone, arguing that survival and progression-free-survival results matter more than response rates, while others remain cautious about the subgroup data and competitive threat.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways new 52-week COMP360 data showing sustained improvement in treatment-resistant depression after an additional dose is driving attention, alongside expectations for the planned NDA filing and expedited FDA review. Many traders see the results and approaching regulatory milestones as bullish, while others remain cautious about approval uncertainty and volatile price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
